Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Parenthetical) - USD ($) $ in Thousands		3 Months Ended
		Sep. 30, 2021	Sep. 30, 2020
Total net revenue		$ 107,442	$ 85,332
Total cost of revenue	[1]	67,918	49,929
Research and development	[2]	14,382	12,148
Products
Total net revenue	[3]	52,759	31,258
Total cost of revenue		31,509	18,426
Services
Total net revenue	[4]	54,683	54,074
Total cost of revenue		36,409	31,503
Revenue from Joint Venture
Total cost of revenue		8,044	1,944
Research and development		579	0
Revenue from Joint Venture | Products
Total net revenue		5,920	2,874
Revenue from Joint Venture | Services
Total net revenue		$ 3,638	$ 2,077

[1] Includes cost of revenue from sales to the China joint venture, an equity method investment of $8,044 and $1,944 for the three months ended September 30, 2021 and September 30, 2020, respectively.

[2] Includes chargeback to the China joint venture, an equity method investment related to research and development project of $579 and $0 for the three months ended September 30, 2021 and September 30, 2020, respectively.

[3] Includes sales to the China joint venture, an equity method investment of $5,920 and $2,874 for the three months ended September 30, 2021 and September      30, 2020, respectively. See Note 14.

[4] Includes sales to the China joint venture, an equity method investment of $3,638 and $2,077 for the three months ended September 30, 2021 and September            30, 2020, respectively. See Note 14.